Envista (NVST) Scheduled to Post Earnings on Wednesday

Envista (NYSE:NVST) is set to issue its quarterly earnings data after the market closes on Wednesday, May 1st. Analysts expect the company to announce earnings of $0.31 per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link.

Envista (NYSE:NVST) last issued its earnings results on Wednesday, February 7th. The company reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.33 by ($0.04). Envista had a positive return on equity of 6.31% and a negative net margin of 3.90%. The company had revenue of $645.60 million during the quarter, compared to analysts’ expectations of $638.37 million. During the same period in the previous year, the company earned $0.52 EPS. Envista’s quarterly revenue was down 2.3% on a year-over-year basis. On average, analysts expect Envista to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Envista Price Performance

Shares of NYSE NVST opened at $20.23 on Wednesday. Envista has a 1-year low of $18.95 and a 1-year high of $39.28. The business has a 50-day moving average of $21.08 and a 200-day moving average of $22.79. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.23 and a quick ratio of 1.90. The company has a market capitalization of $3.48 billion, a price-to-earnings ratio of -33.16, a PEG ratio of 3.73 and a beta of 1.35.

Analysts Set New Price Targets

Several brokerages have recently weighed in on NVST. UBS Group began coverage on Envista in a research report on Friday, January 5th. They issued a “neutral” rating and a $26.00 target price for the company. SVB Leerink began coverage on Envista in a research report on Monday, February 26th. They issued an “underperform” rating and a $19.00 target price for the company. Jefferies Financial Group downgraded Envista from a “buy” rating to a “hold” rating and decreased their target price for the stock from $30.00 to $23.00 in a research report on Friday, February 9th. TheStreet downgraded Envista from a “c” rating to a “d+” rating in a report on Wednesday, February 7th. Finally, William Blair downgraded Envista from an “outperform” rating to a “market perform” rating in a report on Thursday, February 8th. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $29.60.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.